Contact:
Stephanie Berger
Director, Clinical Development
The Clinical Research Group, Inc.
469.585.2079
FOR IMMEDIATE RELEASE
The Clinical Research Group, Inc. Welcomes Dr. Arnold W. Mech as Newest Principal Investigator
Plano, TX, January 6, 2015 – The Clinical Research Group Inc. (TCRG), a global Site Management Organization dedicated to developing top-quality data producers in both the United States and emerging global markets, today announced the addition of Arnold W. Mech, M.D. to their roster of outstanding principal investigators. “Partnering with Dr. Mech represents a significant strategic advance in TCRG’s expansion into the therapeutic area of psychiatry,” notes Donna Behring, President and CEO of The Clinical Research Group. Dr. Mech brings over 20 years of psychiatric clinical trial experience into the partnership. His office is located in Plano, Texas.
About Dr. Mech:
Dr. Mech is a graduate of the Stritch School of Medicine at Loyola University of Chicago. He was founder and director of the Eating Disorders program at the Menninger Clinic and has served on the Faculty of the Karl Menninger School of Mental Health Sciences. He is a nationally recognized speaker who is highly regarded for his expertise across the life-span, holding certifications in child, adolescent, adult, and addiction psychiatry.
Dr. Mech has over 20 years of clinical trial experience in the therapeutic area of psychiatry.
About TCRG, Inc.:
Founded in 2000, The Clinical Research Group, Inc. is celebrating 15 years in business serving the clinical research industry. Specializing in site-level management and intervention, the mission of TCRG is simple: creating clinical trial success one site at a time. TCRG supports and streamlines site-level operations through various programs and solutions that are scalable to meet the needs of sponsors, clinical research organizations, and independent investigative sites.
TCRG manages and supports investigative sites globally. In addition to seasoned clinical trial sites in Puerto Rico, U.S. Virgin Islands, and the Dominican Republic, TCRG has recently expanded into India. Future expansion into other emerging markets is planned for 2015. Such expansion has been made possible and successful by the launch of TCRG’s premier product, the Source Map™ Source Document Management System. Source Map™ is a scalable solution that allows remote access and support for clinical trial sites globally. To learn more about TCRG, Inc. products and services, contact Stephanie Berger, Director of Clinical Development at (469)585-2079 or via email at: Stephanie.b@tcrginc.com.